The Animal Core Unit will be responsible for the procurement, maintenance, surgical manipulation, and treatment of viral antibody free (vAF) experimental animals in the Program Project. These are services not provided by Department of Animal Medicine through its per diem charge which includes only food, water, bedding, and cage cleaning. All Program Project experiments will utilize VAF animals housed in a limited access facility designed to maintain the highest degree of cleanliness. The emphasis on VAF animals will preclude contamination of outcomes by infectious agents. Viral infection in particular not only affects the survival of transplant recipients but also modulates many of the processes to be studied in this Program. The objectives and responsibilities of the Program Project Animal Core Unit are as follows: 1. Provision of viral antibody free (vAF) animals and the maintenance of quarantine Procurement, quarantine, and housing arrangements and overall responsibility for the maintenance and verification of viral antibody free status of animals used in this Project 2. Selective breeding of transgenic and knockout founders and progeny, and congenic strains as directed by program directors Transgenic mice expressing a TcR specific for H-2 Ld class I MHC expressed on CD8+ T cells, CD40 transgenic and knockout mice, CD40L knockout mice, B7 transgenic and knockout mice, and other mutants as described in the individual Projects 3. Experimental manipulation of animals while maintaining VAF status as required by Program Project investigators Administration of reagents, including anti-CD4OL, other monoclonal antibodies, and other specific agents to be developed in the course of the Program; administration of cells in both adoptive transfer and immune system reconstitution studies; preparation of biopsy specimens (e.g. lymph nodes, peripheral blood) obtained under conditions that permit continued VAF status; maintenance of scid mice bearing hybridomas 4. Surgery: Creation and maintenance of dorsal skinfold chambers for intravital microscopic study of allogeneic and xenogeneic islet grafts and the performance of skin grafts 5. Testing for diabetes and skin graft rejection In brief, the Animal Core will provide essential assistance to each Program Project with the management and execution of in vivo studies conducted under viral antibody free conditions. It will maintain all records of animals and procedures and serve as a central facility for the cooperative efforts of the program projects.

Project Start
2000-12-01
Project End
2001-11-30
Budget Start
Budget End
Support Year
4
Fiscal Year
2001
Total Cost
$180,000
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Covassin, L; Laning, J; Abdi, R et al. (2011) Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2r?(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease. Clin Exp Immunol 166:269-80
de Vries, V C; Elgueta, R; Lee, D M et al. (2010) Mast cell protease 6 is required for allograft tolerance. Transplant Proc 42:2759-62
Brehm, Michael A; Bortell, Rita; Diiorio, Philip et al. (2010) Human immune system development and rejection of human islet allografts in spontaneously diabetic NOD-Rag1null IL2rgammanull Ins2Akita mice. Diabetes 59:2265-70
Jurczyk, Agata; Pino, Steven C; O'Sullivan-Murphy, Bryan et al. (2010) A novel role for the centrosomal protein, pericentrin, in regulation of insulin secretory vesicle docking in mouse pancreatic beta-cells. PLoS One 5:e11812
Brehm, Michael A; Shultz, Leonard D; Greiner, Dale L (2010) Humanized mouse models to study human diseases. Curr Opin Endocrinol Diabetes Obes 17:120-5
Racki, Waldemar J; Covassin, Laurence; Brehm, Michael et al. (2010) NOD-scid IL2rgamma(null) mouse model of human skin transplantation and allograft rejection. Transplantation 89:527-36
Brehm, Michael A; Cuthbert, Amy; Yang, Chaoxing et al. (2010) Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. Clin Immunol 135:84-98
Mangada, Julie; Pearson, Todd; Brehm, Michael A et al. (2009) Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice. Diabetes 58:165-73
King, M A; Covassin, L; Brehm, M A et al. (2009) Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 157:104-18
King, Marie; Pearson, Todd; Shultz, Leonard D et al. (2008) A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin Immunol 126:303-14

Showing the most recent 10 out of 48 publications